Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Humanities
Open Access

Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada

Ian Mosby and Jaris Swidrovich
CMAJ March 15, 2021 193 (11) E381-E383; DOI: https://doi.org/10.1503/cmaj.210112
Ian Mosby
Department of History, Ryerson University, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaris Swidrovich
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Sask.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

As the second wave of the pandemic sees case numbers rise to dangerous levels across the country, it has become clear that Indigenous people are particularly vulnerable to coronavirus disease 2019 (COVID-19). The figures released by the Manitoba First Nations COVID-19 Pandemic Response Coordination Team reflect this vulnerability. Despite making up just over 10% of the total population of the province, First Nations people make up 71% of active cases with COVID-19 and 50% of patients in the intensive care unit; the median age of death from COVID-19 for First Nations people is 66 compared with the provincial median of 83 for Manitobans, overall.1

This should come as no surprise to anyone who has read the dozens of studies, reports and royal commission findings published during the past two decades. Study after study has shown the vulnerability of First Nations, Métis and Inuit communities to health crises like the one we are currently facing. This vulnerability is very much the product of a Canadian colonial policy regime that has guaranteed that Indigenous Peoples have reduced access to adequate health care, healthy food and clean water, while also experiencing much greater levels of overcrowded housing, homelessness and incarceration.

All of these factors increase the possibility both of contracting COVID-19 and of having severe health complications as a result. It is therefore imperative that Indigenous Peoples receive priority access to vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

However, many Indigenous people have expressed substantial hesitancy and even opposition to vaccination for COVID-19. After the arrival of 1200 doses of the Moderna vaccine in his home community, former Assembly of First Nations National Chief Matthew Coon Come articulated his concerns in a widely shared social media post, writing “Mistissini is now the experimental rats of this experimental vaccine.”2

Nurse taking a blood sample from a boy at the Alberni Indian Residential School (Port Alberni, BC) as part of a series of nutrition experiments conducted in residential schools between 1948 and 1952.

Nurse takes blood sample from boy at the Alberni Indian Residential School (Port Alberni, BC) as part of a series of nutrition experiments conducted in residential schools between 1948 and 1952.

Image courtesy of F. Royal/National Film Board of Canada/Library and Archives Canada/www.bac-lac.gc.ca/eng/CollectionSearch/Pages/record.aspx?app=fonandcol&IdNumber=3604277&new=-8585888062503706205

Historical legacies

The fears and hesitancy articulated by Coon Come are, of course, not universal, and many Indigenous leaders have come out strongly in support of vaccines. However, the reality is that these concerns are nonetheless widely held by many First Nations, Inuit and Métis people. As former Manitoba Keewatinowi Okimakanak Grand Chief Sheila North explained: “Back in residential school days, [people], that are now elders, remember being used as guinea pigs or [having] vaccines tested on them when they were children without their permission or their family’s permission.”3

These concerns, fears and experiences need to be taken seriously by doctors and other health care professionals and need to be differentiated from the “anti-vax” movements that have thrived on social media in recent years. The reality is that well-documented examples of Indigenous Peoples being subjected to medical experimentation exist. One of the authors of this article has published research regarding a series of nutrition experiments conducted in several Manitoba Cree communities in the 1940s, as well as in six residential schools between 1948 and 1952.4 Historian Maureen Lux has similarly documented multiple instances of medical experimentation on Indigenous Peoples, including a 12-year trial of the experimental bacille Calmette-Guérin vaccine for tuberculosis on Cree and Nakoda Oyadebi infants in Saskatchewan during the 1930s and 1940s.5 A whole range of experimental surgical and drug treatments were also administered to Indigenous patients, without their consent, within Canada’s racially segregated system of Indian Hospitals during the early postwar years.5

The legacies of the racist paternalism that left Indigenous Peoples uniquely vulnerable to medical experimentation and abuse can be seen in the more recent story of Brian Sinclair, who died as a direct result of racist treatment at the hands of hospital staff and physicians. They can also be seen in the testimony of nearly 60 Indigenous women who launched a class action lawsuit seeking damages for what they describe as forced sterilizations by Saskatchewan doctors over the past 25 years.6

Indigenous Peoples, then, have every reason to be wary of the Canadian medical system. Given that recent studies show that Black people, in particular, are much more likely to reject SARS-CoV-2 vaccination than their White counterparts — in large part because of well-documented experiences of medical abuse and experimentation — we need to start taking this seriously.7

Vaccine hesitancy

The influenza A virus (H1N1) pandemic is an instructive example of vaccine hesitancy among Indigenous Peoples. As studies have shown, Indigenous Peoples’ experiences of Canadian colonialism already “deeply affected their perceptions of the [H1N1] vaccine and pandemic” and increased vaccine hesitancy.8 These issues were then exacerbated by problematic public health messaging and actions.

A disturbing example of this occurred in 2009 when, during an H1N1 outbreak, the federal government sent body bags to four Manitoba First Nations communities instead of shipments of antivirals, hand sanitizer and flu kits.9 The story spread and contributed to distrust across the country. Although there is no genetic predisposition to or additional risk of more severe outcomes from H1N1 for Indigenous Peoples, they were nonetheless listed as a stand-alone category of people who should receive the H1N1 vaccine among all identified high-risk groups. Zeroing in on Indigeneity alone meant that many were left feeling like guinea pigs.9

Canada is already setting itself up for similar failures with the SARS-CoV-2 vaccines. Limited and late information about both COVID-19 and the approved vaccines have each contributed to vaccine hesitancy among Indigenous Peoples.10 It also means that those on the ground are being asked to fill an informational vacuum among an already skeptical population with few resources. The lack of information is why Lesa Semmler, member of the Legislative Assembly in Inuvik and a former nurse, has been pushing for community-focused and community-driven educational efforts. “People need time,” she told the CBC. “You need the health education before [the vaccines arrive].”10

Similar to the H1N1 pandemic, then, the prioritization of Indigenous Peoples and communities to receive SARS-CoV-2 vaccines raises questions. Recent statements that Canada could not meet its pledge to end boil water advisories by March 2021 because of COVID-19 — all while early priority shipments of the vaccine are being sent to Indigenous communities — only feeds into the narrative that Indigenous Peoples are being used to test the safety and effectiveness of the vaccine before it is administered to the rest of the population.

Conclusion

What, then, needs to be done to ensure that as many Indigenous people as possible receive SARS-CoV-2 vaccines that we, the authors, believe to be lifesaving?

For a start, doctors and other health professionals need to educate themselves before going into communities to administer vaccines. Too many are unaware of Canada’s shameful histories of racially segregated health care and medical experimentation, and therefore misunderstand the nature of vaccine hesitancy.

Public health messaging about the risks of SARS-CoV-2 infection and the benefits of receiving the vaccine also must clearly be positioned in a way that speaks to Indigenous Peoples’ historical and contemporary experiences with Canadian settler colonialism. Risk attributes must also be described individually rather than simply categorizing Indigeneity as an individual risk category.

This means jettisoning a one-size-fits-all public health messaging strategy. Pandemic messaging will be more effective if delivered directly by Indigenous Elders, leaders and health practitioners who have trust and credibility in their communities. For many communities, this means that public health messaging needs to focus not only on the health and wellness of the people receiving the vaccine, but also on the health and wellness of our families, communities, the land and the next seven generations.

One of the, perhaps insurmountable, short-term problems that we face is that there has never been a reckoning for the legacy of medical experimentation and other abuses targeted at Indigenous Peoples within Canadian medical institutions. In the long term, an inquiry into the history of medical experimentation in Canada and reparations to the affected communities will be required.

Before that happens, though, there also needs to be a vaccine strategy that puts the onus on Canada for doing what is necessary to prove to Indigenous communities that the vaccine is safe, effective and in their best interests. And this should have started months ago.

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    Nations Manitoba First COVID-19 Pandemic Response Coordination Team Weekly Bulletin. Winnipeg: Assembly of Manitoba Chiefs; 2021. Available: https://d5d8ad59-8391-4802-9f0a-f5f5d600d7e9.filesusr.com/ugd/38252a_7918036c62914724a5b6b3afa3231479.pdf?index=true (accessed 2021 Jan. 13).
  2. ↵
    1. Pashagumskum J
    . Former AFN national chief and Cree grand chief speaks out against vaccine. APTN News [Winnipeg] 2020 Jan. 7. Available: www.aptnnews.ca/national-news/former-afn-national-chief-and-cree-grand-chief-speaks-out-against-vaccine/ (accessed 2021 Jan. 13).
  3. ↵
    1. Rodriguez J
    . To tackle vaccine hesitancy, Canada can’t ignore race, racism: health experts. CTV News: Coronavirus 2020 Dec. 16, updated 2020 Dec. 17. Available: www.ctvnews.ca/health/coronavirus/to-tackle-vaccine-hesitancy-canada-can-t-ignore-race-racism-health-experts-1.5234212 (accessed 2021 Jan. 13).
  4. ↵
    1. Mosby I
    . Administering colonial science: nutrition research and human biomedical experimentation in Aboriginal communities and residential schools, 1942–1952. Soc Hist 2013;46:145–72.
    OpenUrl
  5. ↵
    1. Lux MK
    . Separate beds: a history of Indian hospitals in Canada, 1920s–1980s. Toronto: University of Toronto Press; 2016.
  6. ↵
    Indigenous women kept from seeing their newborn babies until agreeing to sterilization, says lawyer. CBC Radio 2018 Nov. 13. Available: www.cbc.ca/radio/thecurrent/the-current-for-november-13-2018-1.4902679/indigenous-women-kept-from-seeing-their-newborn-babies-until-agreeing-to-sterilization-says-lawyer-1.4902693 (accessed 2021 Jan. 13).
  7. ↵
    1. Callaghan T,
    2. Moghtaderi A,
    3. Lueck JA,
    4. et al
    . Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med 2020 Dec. 23 [Epub ahead of print]. doi: 10.1016/j.socscimed.2020.113638.
    OpenUrlCrossRef
  8. ↵
    1. Driedger SM,
    2. Maier R,
    3. Furgal C,
    4. et al
    . Factors influencing H1N1 vaccine behavior among Manitoba Metis in Canada: a qualitative study. BMC Public Health 2015;15:128.
    OpenUrl
  9. ↵
    1. Driedger SM,
    2. Cooper E,
    3. Jardine C,
    4. et al
    . Communicating risk to Aboriginal Peoples: First Nations and Metis responses to H1N1 risk messages. PLoS One 2013;8:e71106.
    OpenUrlPubMed
  10. ↵
    1. Zingel A
    . Work with communities to address vaccine hesitancy, say Indigenous leaders. CBC News North 2021 Jan. 8. Available: www.cbc.ca/news/canada/north/work-with-communities-vaccine-hesitancy-indigenous-leaders-1.5865677 (accessed 2021 Jan. 13).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 193 (11)
CMAJ
Vol. 193, Issue 11
15 Mar 2021
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada
Ian Mosby, Jaris Swidrovich
CMAJ Mar 2021, 193 (11) E381-E383; DOI: 10.1503/cmaj.210112

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada
Ian Mosby, Jaris Swidrovich
CMAJ Mar 2021, 193 (11) E381-E383; DOI: 10.1503/cmaj.210112
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Historical legacies
    • Vaccine hesitancy
    • Conclusion
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • L’expérimentation médicale et les causes de la réticence à la vaccination contre la COVID-19 chez les peuples autochtones du Canada
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • “Patients deserve agency when it comes to their body”: a patient’s experience with endometriosis
  • Notes in still
  • Colonial tuberculosis legacies and the Dynevor Indian Hospital (1908–1934)
Show more Humanities

Similar Articles

Collections

  • Article Types
    • Medicine & Society
  • Topics
    • Canadian government
    • History of medicine
    • Human rights
    • Indigenous health
    • Infectious diseases: COVID-19
    • Medical humanities
    • Patient education
    • Public health
    • Vaccination

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire